Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liangyuan Loquat Leaf Paste (良园枇杷叶膏) is an approved Traditional Chinese Medicine (TCM) oral preparation developed by Hubei Wushi Pharmaceutical. It is formulated as a traditional herbal paste (decoction paste) and has been designated as a 'National Protected Traditional Chinese Medicine Variety' in China. The formulation contains a mixture of botanical extracts, including loquat leaves (Eriobotrya japonica), dried reed root, platycodon, aster, tangerine peel, and licorice extract, along with ephedrine hydrochloride. It is indicated for the treatment of respiratory conditions such as cough, bronchitis, asthma, and wind-heat common cold by clearing the lungs, resolving phlegm, and relieving cough.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Liangyuan Loquat Leaf Paste.